Insider · CIK 0001242117

BENNER STEVEN E

Reports to the SEC for 2 companies · SEATTLE, WA

sec.gov

Transactions

Companies

Filings

CIK

0001242117

Forms 4 and 5

Insider transactions

24 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2013-03-21	CTI BIOPHARMA CORPA Award	EVP, Chief Medical Officer	AAward	+297K sh	—	—	363,371
2013-03-21	CTI BIOPHARMA CORPPerformance RightsA Award	EVP, Chief Medical Officer	AAward	+253K sh	—	—	253,438
2013-03-06	CTI BIOPHARMA CORPG Gift	EVP, Chief Medical Officer	GGift	−33.3K sh	—	—	66,666
2013-03-06	CTI BIOPHARMA CORPG Gift	EVP, Chief Medical Officer	GGift	+33.3K sh	—	—	33,334
2012-06-13	CTI BIOPHARMA CORPA Award	EVP, Chief Medical Officer	AAward	+500K sh	—	—	500,000
2006-07-16	PDL BIOPHARMA, INC.F Tax Payment	SVP & Chief Med. Off.	FTax Payment	−1,073 sh	$17.40	−$18.7K	10,927
2005-07-13	PDL BIOPHARMA, INC.A Award	SVP & Chief Med. Off.	AAward	+12K sh	—	—	12,000
2004-09-13	PDL BIOPHARMA, INC.S Sale	SVP & Chief Med. Off.	SSale	−11.4K sh	$19.60	−$223K	0
2004-09-13	PDL BIOPHARMA, INC.M Exercise/Conversion	SVP & Chief Med. Off.	MExercise/Conversion	+3,950 sh	$8.81	+$34.8K	3,950
2004-09-13	PDL BIOPHARMA, INC.S Sale	SVP & Chief Med. Off.	SSale	−3,950 sh	$19.56	−$77.3K	0
2004-09-13	PDL BIOPHARMA, INC.M Exercise/Conversion	SVP & Chief Med. Off.	MExercise/Conversion	+12.4K sh	$8.81	+$109K	12,350
2004-09-13	PDL BIOPHARMA, INC.S Sale	SVP & Chief Med. Off.	SSale	−12.4K sh	$19.55	−$241K	0
2004-09-13	PDL BIOPHARMA, INC.M Exercise/Conversion	SVP & Chief Med. Off.	MExercise/Conversion	+11.3K sh	$8.81	+$99.1K	11,250
2004-09-13	PDL BIOPHARMA, INC.S Sale	SVP & Chief Med. Off.	SSale	−832 sh	$19.53	−$16.2K	0
2004-09-13	PDL BIOPHARMA, INC.M Exercise/Conversion	SVP & Chief Med. Off.	MExercise/Conversion	+7,868 sh	$8.81	+$69.3K	7,868
2004-09-13	PDL BIOPHARMA, INC.S Sale	SVP & Chief Med. Off.	SSale	−7,868 sh	$19.50	−$153K	0
2004-09-13	PDL BIOPHARMA, INC.Employee Stock Option (Right to buy)M Exercise/Conversion	SVP & Chief Med. Off.	MExercise/Conversion	−56.3K sh	—	—	93,750
2004-09-13	PDL BIOPHARMA, INC.M Exercise/Conversion	SVP & Chief Med. Off.	MExercise/Conversion	+832 sh	$8.81	+$7,329.92	832
2004-09-13	PDL BIOPHARMA, INC.S Sale	SVP & Chief Med. Off.	SSale	−11.3K sh	$19.70	−$222K	0
2004-09-13	PDL BIOPHARMA, INC.M Exercise/Conversion	SVP & Chief Med. Off.	MExercise/Conversion	+6,000 sh	$8.81	+$52.9K	6,000
2004-09-13	PDL BIOPHARMA, INC.S Sale	SVP & Chief Med. Off.	SSale	−6,000 sh	$19.69	−$118K	0
2004-09-13	PDL BIOPHARMA, INC.M Exercise/Conversion	SVP & Chief Med. Off.	MExercise/Conversion	+2,640 sh	$8.81	+$23.3K	2,640
2004-09-13	PDL BIOPHARMA, INC.S Sale	SVP & Chief Med. Off.	SSale	−2,640 sh	$19.65	−$51.9K	0
2004-09-13	PDL BIOPHARMA, INC.M Exercise/Conversion	SVP & Chief Med. Off.	MExercise/Conversion	+11.4K sh	$8.81	+$100K	11,360

Recent filings

Accepted (ET)
Mar 224
BENNER STEVEN E0000891293-13-000015
SEC(opens sec.gov)
Mar 74
BENNER STEVEN E0000891293-13-000002
SEC(opens sec.gov)
Jun 154
BENNER STEVEN E0000891293-12-000029
SEC(opens sec.gov)
Jul 184
PDL BIOPHARMA, INC.0001140361-06-010358
SEC(opens sec.gov)
Jul 154
BENNER STEVEN E0001140361-05-005271
SEC(opens sec.gov)
Sep 144
BENNER STEVEN E0001140361-04-005277
SEC(opens sec.gov)

Companies

Address

3101 WESTERN AVE SUITE 600

SEATTLE, WA, 98121